| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.92▼ | 8.92▼ | 8.92▼ | 8.91▼ | 8.92▼ |
| MA10 | 8.79▼ | 8.79▼ | 8.79▼ | 8.88▼ | 9.52▼ |
| MA20 | 8.86▼ | 8.86▼ | 8.88▼ | 8.90▼ | 9.44▼ |
| MA50 | 8.92▼ | 9.03▼ | 9.15▼ | 9.66▼ | 7.46▲ |
| MA100 | 9.38▼ | 9.75▼ | 10.08▼ | 9.28▼ | 7.23▲ |
| MA200 | 10.31▼ | 9.83▼ | 9.97▼ | 7.91▲ | 12.01▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.022▲ | 0.033▲ | 0.036▲ | 0.032▲ | -0.217▼ |
| RSI | 48.108▼ | 47.359▼ | 46.539▼ | 45.518▼ | 51.006▲ |
| STOCH | 54.947 | 54.947 | 53.944 | 43.910 | 15.201▼ |
| WILL %R | -79.412▼ | -79.412▼ | -79.412▼ | -71.468 | -81.155▼ |
| CCI | 15.502 | 15.502 | -2.125 | -32.947 | -65.486 |
|
Wednesday, November 26, 2025 08:31 AM
Valneva's Phase 2 data show strong, lasting immunity for its Pfizer-partnered Lyme vaccine as the company consolidates operations in France.
|
|
Wednesday, November 26, 2025 05:48 AM
Valneva SE (NASDAQ:VALN) saw its stock move higher on Wednesday after the company released final Phase II results for its Lyme disease vaccine candidate, VLA15, showing robust immune responses ...
|
|
Friday, November 21, 2025 05:06 AM
Q3 2025 Earnings Call Transcript November 20, 2025 Valneva SE misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $-0.3. Operator: Good day, and thank you for standing by.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/12/25 | 8.83 | 8.86 | 8.6601 | 8.84 | 8,314 |
| 03/12/25 | 8.65 | 8.75 | 8.5606 | 8.65 | 11,993 |
| 02/12/25 | 8.845 | 8.94 | 8.69 | 8.77 | 27,909 |
| 01/12/25 | 9.15 | 9.2005 | 8.87 | 8.91 | 14,527 |
| 28/11/25 | 9.41 | 9.41 | 9.21 | 9.355 | 20,190 |
| 26/11/25 | 8.72 | 9.6165 | 8.57 | 9.54 | 98,223 |
| 25/11/25 | 8.78 | 8.8219 | 8.63 | 8.74 | 5,637 |
| 24/11/25 | 8.75 | 8.9162 | 8.665 | 8.82 | 9,395 |
| 21/11/25 | 8.71 | 8.73 | 8.61 | 8.62 | 14,800 |
| 20/11/25 | 8.71 | 8.8499 | 8.53 | 8.53 | 23,120 |
|
|
||||
|
|
||||
|
|